Wellington Management Group
PNT

Wellington Management Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Wellington Management Group’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-343,410
Closed -$3.53M – 2294
2021
Q2 		$3.53M Sell
343,410
-4,364
-1% -$44.4K ﹤0.01% 1571
2021
Q1 		$3.65M Sell
347,774
-530,058
-60% -$7.19M ﹤0.01% 1494
2020
Q4 		$12.2M Sell
877,832
-30,839
-3% -$428K ﹤0.01% 1138
2020
Q3 		$13.1M Buy
+908,671
New +$12.4M ﹤0.01% 1033

Other funds holding PNT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Wellington Management Group's PNT Position: Q3 2021 in Review

Wellington Management Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2021, closing a stake of 343,410 shares — an estimated $3.53M sold.

Wellington Management Group first reported a position in PNT in Q3 2020 and held it in 4 quarters. The position peaked at $13.1M in Q3 2020. 34 funds tracked by Wall St. Rank hold PNT as of Q3 2021.

  • Wellington Management Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Wellington Management Group sold 343,410 POINT Biopharma Global Inc. Common Stock shares in Q3 2021, an estimated $3.53M.
  • Wellington Management Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Wellington Management Group's POINT Biopharma Global Inc. Common Stock position peaked at $13.1M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2021.

Based on Wellington Management Group's 13F filing for Q3 2021, filed 15 Nov 2021.